diltiazem has been researched along with Lambert-Eaton Myasthenic Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, Y; Hiroi, Y; Maemura, K; Nagai, R; Nakamura, F; Nakao, T; Ohno, M; Takeda, N; Tsuchiya, N | 1 |
| Hidelaratchi, MD; Pathirana, KD | 1 |
| Hara, Y; Ueno, S | 1 |
3 other study(ies) available for diltiazem and Lambert-Eaton Myasthenic Syndrome
| Article | Year |
|---|---|
Exacerbation of Lambert-Eaton myasthenic syndrome caused by an L-type Ca2+ channel antagonist.
Topics: Aged; Atherectomy, Coronary; Calcium Channel Blockers; Coronary Stenosis; Diltiazem; Disease Progression; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Muscle, Skeletal; Myocardial Ischemia | 2003 |
Exacerbation of symptoms due to diltiazem in a patient with Lambert-Eaton myasthenic myopathic syndrome.
Topics: Aged; Diltiazem; Disease Progression; Electromyography; Follow-Up Studies; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Myocardial Ischemia; Neurologic Examination; Risk Assessment; Severity of Illness Index; Sri Lanka | 2004 |
Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.
Topics: Autoantibodies; Calcium Channels; Coronary Disease; Diagnosis, Differential; Diltiazem; Electromyography; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Neurologic Examination | 1992 |